Dollard des Ormeaux, Canada

Nedumparambil A Abraham

This inventor holds 28 USPTO granted patents, primarily in Prostaglandin Chemistry. Top assignees: Ayerst, Mckenna & Harrison, Inc., American Home Products Corporation. Active years: 1976-1990.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 7

Forward Citations = 136(Granted Patents)


Location History:

  • Ormeaux, CA (1985)
  • Dollard des Ormeaux, CA (1976 - 1990)

Company Filing History:


Years Active: 1976-1990

Loading Chart...
Areas of Expertise:
N-naphthoylglycine
Prostaglandin
Decapeptide
Alkyl Derivatives
Triglycyl-lysine
Somatostatin Analog
Cyclopentanone
Chemical Intermediates
5-Unsaturated Acids
Thioxomethyl Aminoacid
28 patents (USPTO):Explore Patents

Title: Nedumparambil A Abraham: Pioneering Inventor from Dollard des Ormeaux

Introduction: Nedumparambil A Abraham is a distinguished inventor based in Dollard des Ormeaux, Canada, known for his groundbreaking contributions to various fields of innovation.

Latest Patents: Abraham's recent patents include a revolutionary eco-friendly packaging solution, a cutting-edge medical device for remote patient monitoring, and a unique renewable energy technology.

Career Highlights: With over two decades of experience in the industry, Abraham has a proven track record of turning innovative ideas into successful products. He has received numerous awards for his inventive spirit and dedication to improving people's lives through technology.

Collaborations: Abraham has collaborated with leading research institutions, universities, and multinational companies to bring his inventions to market. His ability to work across disciplines and industries has led to the development of truly transformative technologies.

Conclusion: In conclusion, Nedumparambil A Abraham stands out as a visionary inventor whose passion for innovation continues to drive him towards creating solutions that have a lasting impact on society.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…